AI's promise, biotech's peril: How unequal access to computing power threatens medical breakthroughs
The biotech industry stands at a fork in the road. One way leads to a future in which AI-driven breakthroughs remain the exclusive domain of pharmaceutical giants with billion-dollar budgets. The ...
More than three years after ChatGPT debuted, AI has become a part of everyday life — and professors and students are still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results